Classes
Publications
- Immunity following SARS-CoV-2 vaccination in autoimmune neurological disorders treated with rituximab or ocrelizumab2023 | First Faculty of Medicine
- Neurofilament levels are associated with blood-brain barrier integrity, lymphocyte extravasation, and risk factors following the first demyelinating event in multiple sclerosis2021 | First Faculty of Medicine
- Peripheral blood lymphocytes immunophenotyping predicts disease activity in clinically isolated syndrome patients2017 | First Faculty of Medicine
- Toxocara spp. seronegativity in Czech patients with early form of multiple sclerosis - Clinically isolated syndrome2017 | First Faculty of Medicine
- Protective associations of HDL with blood-brain barrier injury in multiple sclerosis patients2015 | First Faculty of Medicine
- Multiple sclerosis2013 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Third Faculty of Medicine, Second Faculty of Medicine
- Dipeptidyl peptidase-IV in synovial fluid and in synovial fluid mononuclear cells of patients with rheumatoid arthritis2010 | First Faculty of Medicine
- High-dose immunosuppressive therapy with PBPC support in the treatment of poor risk multiple sclerosis2000 | Central Library of Charles University
- Complement System Deficiencies in Elite Athletes2024 | First Faculty of Medicine
- SARS-CoV-2 Specific Humoral Immune Responses after BNT162b2 Vaccination in Hospital Healthcare Workers2022 | First Faculty of Medicine
Loading network view...
